Sun-21-06-2015, 07:01 AM
(This post was last modified: Sun-21-06-2015, 07:17 AM by Quest4Cure.)
(Sat-20-06-2015, 21:21 PM)Fred Wrote: Sounds like what they are trying here could be the way to go then. However I could again be lucky as it's a training hospital that I go to, and it could just be something they are testing out.
Hi Fred,
Check online for psoriasis clinical studies in your area. Many big Pharms post clinical studies in all countries available during the different phases as open or closed studies.I hope there is one in your country close for you.
I have read where the gene marker for PSA has been Identified. Scientists have found a PSA gene marker on what is called a locus. A specific place on a chromosome where genetic variations happen. Scientisits have found a genetic variation or gene marker for psoriatic arthritis on a locus on chromosome 5. Scientists found this marker to make a patient prone to PSA and not Psoriasis. Now it's narrowed down to the IL-23 monoclonal antibody drug is the next step for research for PsA.
Also another med for Psoriasis has been approved in the U.S. IL-17a interleukin pathway 17-A
Secukinumab, a fully human anti-interleukin-17A monoclonal antibody for P. & PSA. Hope it's available for you. I read it can clear P. Patients with 40%-60% coverage in 3-4 weeks.
Side effects are smiling , laughing, wearing shorts & Swim suits, even using less vacuum bags....
Science is bringing greater knowledge & understanding for research by Big pharms around the world.
Good news!